These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38708825)

  • 1. Topical Vancomycin is More Efficient than Povidone-Iodine Treatment in Controlling Bacterial Growth in Methicillin-Resistant
    Alkan Y; Kaymaz A; Behcet M; Bayrak A
    Curr Eye Res; 2024 Sep; 49(9):923-929. PubMed ID: 38708825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Tas T; Kucukbayrak A; Hakyemez IN; Mengeloglu FZ; Simavli H; Ozyalvacli G; Erdurmus M
    Cornea; 2013 Jul; 32(7):1052-7. PubMed ID: 23665649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis.
    Ucgul AY; Behcet M
    Int Ophthalmol; 2021 Apr; 41(4):1395-1402. PubMed ID: 33506369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrastromal Administration of Vancomycin to Maximize Its Early Effect on Methicillin-resistant Staphylococcus Aureus Keratitis: A Rabbit Study.
    Ucgul AY; Ucgul RK; Behcet M
    Ocul Immunol Inflamm; 2022 Aug; 30(6):1430-1435. PubMed ID: 33974478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Vancomycin 5% Is More Efficacious Than 2.5% and 1.25% for Reducing Viable Methicillin-Resistant Staphylococcus aureus in Infectious Keratitis.
    Romanowski EG; Romanowski JE; Shanks RMQ; Yates KA; Mammen A; Dhaliwal DK; Jhanji V; Kowalski RP
    Cornea; 2020 Feb; 39(2):250-253. PubMed ID: 31658169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of daptomycin on experimental methicillin-resistant Staphylococcus aureus keratitis in rabbits.
    Mengeloğlu FZ; Küçükbayrak A; Bucak YY; Erdurmuş M; Taş T; Özyalvaçlı G; Bayram R; Bucak Ö; Akdeniz H
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):893-9. PubMed ID: 24070366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ; Hume EB; Moreau JM; Caballero AR; Cannon BM; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1432-7. PubMed ID: 10798659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
    Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of topical povidone-iodine versus topical ofloxacin on experimental Staphylococcus keratitis.
    Melki SA; Safar A; Yaghouti F; Scharper P; Scharper M; Zeligs B; MacDowell AL; Goldberg MA; Lustbader J
    Graefes Arch Clin Exp Ophthalmol; 2000 May; 238(5):459-62. PubMed ID: 10901479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
    Oguz H; Ozbilge H; Oguz E; Gurkan T
    Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
    Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR
    Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis.
    Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Kowalski RP; Romanowski EG; Mah FS; Shanks RM; Gordon YJ
    Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
    Callegan MC; Hill JM; Insler MS; Hobden JA; O'Callaghan RJ
    Curr Eye Res; 1992 Nov; 11(11):1111-9. PubMed ID: 1483341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The In Vitro Evaluation of Tigecycline and the In Vivo Evaluation of RPX-978 (0.5% Tigecycline) as an Ocular Antibiotic.
    Romanowski EG; Kowalski TA; O'Connor KE; Yates KA; Mah FS; Shanks RM; Kowalski RP
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):119-26. PubMed ID: 26545167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative cold atmospheric plasma (iCAP) decreases corneal ulcer formation and bacterial loads and improves anterior chamber health in methicillin resistant Staphylococcus aureus keratitis.
    Carr MA; Marquart ME; Sanchez M; Saleem W; Wellington OI; Lovell KM; McCallister A; Lightfoot V; Ost EB; Wise HZ; Huang B; Sharma AC
    Exp Eye Res; 2023 Dec; 237():109692. PubMed ID: 37884203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis.
    Barequet IS; Bourla N; Pessach YN; Safrin M; Yankovich D; Ohman DE; Rosner M; Kessler E
    Graefes Arch Clin Exp Ophthalmol; 2012 Feb; 250(2):223-9. PubMed ID: 21947265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
    Callegan MC; Hobden JA; Hill JM; Insler MS; O'Callaghan RJ
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3017-23. PubMed ID: 1399405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
    Dajcs JJ; Moreau JM; Stroman DW; Schlech BA; Ke TL; Thibodeaux BA; Girgis DO; Caballero AR; O'Callaghan RJ
    Curr Eye Res; 2001 Jul; 23(1):60-3. PubMed ID: 11821987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.